Literature DB >> 10393829

Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis.

F Cetta, M R Pelizzo, M C Curia, A Barbarisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10393829      PMCID： PMC1866672          DOI： 10.1016/S0002-9440(10)65091-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  17 in total

1.  Comment on clinical and prognostic relevance of Ret-PTC activation in patients with papillary thyroid carcinoma.

Authors:  F Cetta; M Gori; N Raffaelli; C Baldi; G Montalto
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group.

Authors:  C Bülow; S Bülow
Journal:  Int J Colorectal Dis       Date:  1997       Impact factor: 2.571

3.  Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

Authors:  Y E Nikiforov; J M Rowland; K E Bove; H Monforte-Munoz; J A Fagin
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 4.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

5.  Thyroid cancer and the Chernobyl accident. Are long-term and long distance side effects of fall-out radiation greater than estimated?

Authors:  F Cetta; G Montalto; M Petracci; A Fusco
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

6.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Thyroid carcinoma associated with familial adenomatous polyposis.

Authors:  F Cetta; P Toti; M Petracci; G Montalto; A Disanto; F Lorè; A Fusco
Journal:  Histopathology       Date:  1997-09       Impact factor: 5.087

Review 8.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.

Authors:  H R Harach; G T Williams; E D Williams
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

9.  Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

Authors:  S Olschwang; A Tiret; P Laurent-Puig; M Muleris; R Parc; G Thomas
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.

Authors:  R Caspari; S Olschwang; W Friedl; M Mandl; C Boisson; T Böker; A Augustin; M Kadmon; G Möslein; G Thomas
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150
View more
  17 in total

1.  Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules.

Authors:  Tomoko Fujimoto; Mitsuyoshi Hirokawa; Hisashi Ota; Tomonori Yabuta; Mitsuhiro Fukushima; Kaoru Kobayashi; Nobuyuki Amino; Akira Miyauchi
Journal:  J Med Ultrason (2001)       Date:  2014-07-03       Impact factor: 1.314

2.  Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.

Authors:  Nicolás Casellas-Cabrera; Yaritza Díaz-Algorri; Víctor J Carlo-Chévere; María González-Pons; Natalia Rodríguez-Mañón; Julyann Pérez-Mayoral; Carlos Bertrán-Rodríguez; Marievelisse Soto-Salgado; Francis M Giardiello; Segundo Rodríguez-Quilichini; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

3.  Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer.

Authors:  Chisato Tomoda; Akira Miyauchi; Takashi Uruno; Yuuki Takamura; Yasuhiro Ito; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Seiji Kuma; Kanji Kuma; Kennichi Kakudo
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

4.  Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.

Authors:  Taina T Nieminen; Christopher J Walker; Alisa Olkinuora; Luke K Genutis; Margaret O'Malley; Paul E Wakely; Lisa LaGuardia; Laura Koskenvuo; Johanna Arola; Anna H Lepistö; Pamela Brock; Ayse Selen Yilmaz; Ann-Kathrin Eisfeld; James M Church; Päivi Peltomäki; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-03       Impact factor: 6.568

Review 5.  Gastrointestinal manifestations of endocrine disease.

Authors:  Christina Maser; Arnbjorn Toset; Sanziana Roman
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

6.  Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.

Authors:  Rachel A Levy; Vanessa W Hui; Rupa Sood; Stephanie Fish; Arnold J Markowitz; Richard J Wong; José G Guillem
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

7.  Multiple primary cancers of the colon, rectum, and the thyroid gland.

Authors:  Ahmad Zubaidi
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

8.  Increasing incidence of thyroid cancer in Basilicata: an Italian study.

Authors:  M Capezzone; E Morabito; P Bellitti; P Giannasio; D De Sanctis; R Bruno
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

9.  Familial adenomatous polyposis-rendering a diagnosis based on recognition of an unusual primary thyroid neoplasm.

Authors:  David F Schaeffer; Eric M Yoshida; David A Owen; Kenneth W Berean
Journal:  Case Rep Med       Date:  2011-03-02

10.  Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.

Authors:  L Jin; A Burniat; J-E Dumont; F Miot; B Corvilain; B Franc
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.